Jason Liang

Jason Liang

Auto-generated profile, based on publicly available information

Jason Liang

Department of Discovery Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA; Department of Microchemistry, Proteomics and Lipidomics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Cell Reports
Verified
Journal Article
Open access
AVAvinashnarayan Venkatanarayan
Avinashnarayan Venkatanarayan
JLJason Liang
Jason Liang
IYIvana Yen
Ivana Yen
FSFrances Shanahan
Frances Shanahan
BHBenjamin Haley
Benjamin Haley
SMShiva Malek
Shiva Malek
KRAS, which is mutated in ∼30% of all cancers, activates the RAF-MEK-ERK signaling cascade. CRAF is required for growth of KRAS mutant lung tumors, but the requirement for CRAF kinase activity is unknown. Here, we show that subsets of KRAS mutant tumors are dependent on CRAF for growth. Kinase-dead but not dimer-defective CRAF rescues growth inhibition, suggesting that dimerization but not kinase activity is required. Quantitative proteomics demonstrates increased levels of CRAF:ARAF dimers in KRAS mutant cells, and depletion of both CRAF and ARAF rescues the CRAF-loss phenotype. Mechanistically, CRAF depletion causes sustained ERK activation and induction of cell-cycle arrest, while treatment with low-dose MEK or ERK inhibitor rescues the CRAF-loss phenotype. Our studies highlight the role of CRAF in regulating MAPK signal intensity to promote tumorigenesis downstream of mutant KRAS and suggest that disrupting CRAF dimerization or degrading CRAF may have therapeutic benefit.

1 January 2010 in Journal of Strength & Conditioning Research
Verified
Journal Article
Open access
THTravis Harvey
Travis Harvey
BSBrian D Shelmadine
Brian D Shelmadine
JMJennifer J Moreillon
Jennifer J Moreillon
JLJason Liang
Jason Liang
LGLori Greenwood
Lori Greenwood
DWDarryn Willoughby
Darryn Willoughby
Inflammation response in exercise of healthy humans is significantly different than that which is commonly reported for chronic inflammatory conditions. Regardless of the scenario, cytokines such as Tumor Necrosis Factor (TNF)-α and Interleukin (IL)-1b have demonstrated pro-inflammatory functions, while IL-6 has demonstrated versatile pro- and anti-inflammatory roles when exercise is a factor. Prolonged skeletal muscle contractions of sufficient intensity have been shown to induce significant muscle protein damage and a complex inflammatory cascade involving IL-6 and, separately, Heat Shock Proteins (HSP), and components of the Mitogen-Activated Protein Kinase (MAPK) pathway. This cascade not completely understood in any scenario, particularly in humans. Thus the role of inflammation in regards to exercise, particularly resistance training, has not been elucidated. To determine the effects of concentric (CON) and eccentric (ECC) contractions on creatine kinase (CK), lactate dehydrogenase (LDH), and IL-6 signaling in regards to IL-1b, TNF-α, HSP-72, Nuclear Factor-kappa B (NF-?B), p38 MAPK, Signal Transducer and Activator of Transcription (STAT)-1 and STAT-3 and the potential cytoprotection HSP-27. Six active males (19.33 ± 1.03 yrs; 181.94 ± 6.40 cm; 72.83 ± 12.78 kg) participated in two separate bouts of 10 × 10 unilateral isokinetic knee extensions at 30°/sec. Each bout consisted of either CON or ECC contractions on either the right or left leg; each contraction type and leg was utilized once for each subject. Isokinetic strength tests were performed five days pre- and 24 and 48 hours post-exercise. Serum CK, LDH, IL-6, IL-1b, and TNF-α were assessed immediately preexercise (PRE), immediately post-exercise (PX), and at 2, 6, 24, and 48 hr PX. IL-6, HSP-27, and HSP-72, NF-?B, p38 MAPK, STAT-1 and STAT-3 protein and mRNA expression of IL-6, HSP-27, and HSP-72 were assessed from vastus lateralis biopsies (Bergstrom ) collected at PRE, PX, and 2 and 6 hr PX. Repeated measures MANOVAs and subsequent univariate analyses were performed on all data. Peak torque decreased (p < 0.05) at 24 and 48 hr PX. CK, but not LDH, increased (p < 0.05) similarly following CON and ECC. Serum cytokines were different (p < 0.05) between CON and ECC, but did not change over time. In muscle, NF-?B (p < 0.05) increased and STAT-1 decreased (p < 0.05). ECC contractions demonstrated significantly greater expression for IL-6, p38 MAPK, and STAT-3 than did CON, with a trend (p = 0.093) for STAT-1. There was significant CON/ECC interaction among NF-?B and STAT-1 and a trend (p = 0.074) for HSP-72. Skeletal muscle mRNA expression demonstrated no significant results. Both CON and ECC bouts demonstrated muscle damage and fatigue, but were not sufficient to induce a systemic inflammatory response. Intramuscular inflammatory response was most robust for NF-?B and STAT-1. The hypothesis of ECC stimulating the IL-6 pathway more so than CON is supported the relationship in expression of IL-6, p38 MAPK, STAT-1 and STAT-3. This is novel evidence of a relationship among these factors. Bouts of resistance exercise that include ECC contractions can favorably affect the exercise inflammation response; perhaps more so than lower intensity CON-only contractions.